A Trial Evaluating the Efficacy and Safety of Prophylactic Administration of Concizumab in Haemophilia A and B Patients With Inhibitors

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
This trial is conducted in Africa, Asia, Europe and North America. The aim of the trial is to assess the efficacy of concizumab administered s.c. (subcutaneously, under the skin) once daily in preventing bleeding episodes in haemophilia A and B patients with inhibitors.
Epistemonikos ID: 249495f0697a38f3667b82bae8173d173f7efee6
First added on: May 20, 2024